Member Info for Bunsie

Hi Ruck,
Give it a rest please, it is now tiresome. You are baiting Inanaco

Yes you obviously know your field of expertise, that is quite obvious, but scoring points here is not achieving much. You know Inanaco is focused on the research and science, please don't distract him on all this, we need his attention, as with others (I think) on the progress of the science, as we all must now know by now is what Scancell is all about.
Thank you
ATB

Looking at what we have in the pipeline, if (IF) any or more come to fruition then could be beyond all of our dreams, not yet a reality though, I know that much

Ok Ruck,
I'll give up on the positives, maybe just sell at a massive loss.
But... what if Scancell comes good in the next few years, all trials come out superb, our product(s) are in great demand globally and we gave up on this great little Bio.

I do still have confidence on their product line, maybe not on their marketing.

I would not employ you to market Scancell though, no offence to you intended

That's all I have to say really.
ATB

Evening Ruck,
Way back, nearly 10 years we looked at this and a single product sold for 1 billion, so then it was determined that SCIB1 to be valued at £7.88 a share on its then Mcap with Immunobody alone. That was based on real transactions.

I know a lot has happened since then, but Scancell has built substantially on its product line since then and would be good for a change to sing its praises. Please try to find some positives, I think we all know there are some negatives regarding funding and delays to the program and to some the BOD for lack of marketing.
Can you think of any positives? go on dig deep there must be some?
ATB

Ruck,
You really must not make statements like this please without your reasoning, it is misleading. Back it up with real data please, just adding IMO doesn't cut it really. I think & IMO is gash and misleading.

Hi Ruck,
You have made statement, back it up with your research please.
Looking forward to your detailed statistics, can't wait for it, maybe I may learn something from you for once.
I am open to real data from you for us all to diagnose and make our own decisions.
ATB

Hi Chester,
I'll take a look at my crystal ball and let you know asap, but at 2p I would say buy plenty and wait for £8-£10.
That would be my strategy anyway, but don't miss the boat!
ATB
I will sit in the positive camp for the moment, rather than get depressed and negative.

Wasn't it Moditope that initially caused the delays, their "Jewel in the Crown"? I may be wrong as it was a long time ago.

I guess one needs to be mindful of what one posts, may come back and bite you! haha
BTW I don't disagree with the valuation though

Inan,
Didn't a company with just one product (not even a platform) sell for 1 billion back around 2012'ish?

sorry about the typos, Chinese delivered , so distracted by the aroma of tasty food!

Tony,
Welcome to our BB which has been running for a long time, 10+ years.
We do have some very good researchers regarding the IP/Science, but we also have a few very negative posters, so read between the lines!

I really think you have done well to get into this Bio at such a low buy in price, your risk factor compared to us Long Term Holders I believe to be very low, plus Scancell is now getting closer to the "end game", perhaps a year or three, so sit tight and enjoy the ride.

Pleas feel feel free to ask questions, as we do have a wealth of experienced people to help you along they way, I will say you will no doubt figure out who are the "Mr Negatives" and who actually does the detailed research in order for you to make your own decisions.
ATB
Bunsie

Nice one Ray,
I think a fairly cautious update, well done.
Just must mention that at our current SP , a fairly good punt really, not quite the risk LTH are sitting at.
Just wish in hindsight I could invest my capital at these prices. lol
ATB

Sorry to drop an atom bomb, but I am disheartened by some of our traders who cannot see what Scancell has here, it's just taking longer than we may have expected.

Many invest in the science, but some invest on AIM just to make a fast buck or two. AIM is known to be risky and attracts the bottom feeders, as in penny shares, just little stuff really. If they make a living in pushing or pulling the penny or two on a share then maybe they scrape together a living for really doing nothing.

I am of the opinion that Scancell, although on AIM, sits in a different league .

Stay safe everybody and follow the science, not the fast buck

Just my opinion though.
ATB

Ruck,
Don't ask me I'm just an Airline Pilot, I just press buttons really with todays automation in business Jets
Ask our science team, but really good news, don't you think?

Guess our science experts will digest all this and translate it to understandable lingo , Inan, Crumbs, Berm, etc

That article was accepted 26 April 2020, so very up-to-date. Well done Crumbs, love it

Crumbs
Did a google and found it already, so ignore my last post
Thanks

Afternoon Crumbs
Could you post the link to that info please?
Many thanks in anticipation
ATB

Can't really disagree with that statement FTSE